Industry comparison
Biotechnology
CodeNameLastChange(%)P/EdescendingYield (%)P/E Range
BBOTBridgeBio Oncology Therapeutics Inc11.5-4.49%48.16--PE
After Hours不變 11.5 0.00%
STOKStoke Therapeutics29.28-5.46%45.54--PE
After Hours不變 29.71 +1.47%
LENZLENZ Therapeutics18.14-2.42%45.3532.39PE
After Hours不變 18.5 +1.98%
KRYSKrystal Biotech282.01-3.35%43.75--PE
After Hours不變 283.25 +0.44%
CORTCorcept Therapeutics35.39-4.45%42.57--PE
After Hours不變 35.42 +0.08%
CSBRChampions Oncology7.1726-0.10%42.241.45PE
After Hours不變 7.28 +1.50%
XOMAXOMA Royalty Corporation28.79-1.94%39.151.87PE
After Hours不變 28.79 0.00%
TBPHTheravance Biopharma20.11-2.43%36.16--PE
After Hours不變 20.11 0.00%
ARGXargenx SE813.24+1.74%34.19--PE
After Hours不變 813.23 0.00%
VRTXVertex Pharmaceuticals438.92-2.36%31.68--PE
After Hours不變 438.06 -0.20%
IMTXImmatics NV9.92+0.92%29.95--PE
After Hours不變 9.92 0.00%
AUPHAurinia Pharmaceuticals14.87-2.36%27.2--PE
After Hours不變 14.81 -0.40%
CTNMContineum Therapeutics11.84+0.68%26.3--PE
After Hours不變 11.84 0.00%
NAGENiagen Bioscience Inc6.31--26.29--PE
After Hours不變 6.31 0.00%
PLXProtalix BioTherapeutics2.06--25.75--PE
After Hours不變 2.0503 -0.47%
SMMTSummit Therapeutics17.27-2.15%25.11--PE
After Hours不變 17.45 +1.04%
ICCCImmuCell Corp6.64+0.30%23.64--PE
After Hours不變 6.64 0.00%
RPRXRoyalty Pharma plc39.72-1.22%22.982.22PE
After Hours不變 39.72 0.00%
ADMAADMA Biologics17.5-4.27%21.26--PE
After Hours不變 17.6 +0.57%
RAPPRapport Therapeutics Inc.26.86-2.04%21.13--PE
After Hours不變 27.26 +1.49%
Smiley faceQuotes are at least 15-min delayed:2026/01/15 17:33 EDT
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.